If you could vote on Brexit now which option would you choose?
   

U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-olds


The U.S. Food and Drug Administration on Monday authorized the use of a third dose of the Pfizer (PFE.N) and BioNTech COVID-19 vaccine for children ages 12 to 15, and narrowed the interval for booster shot eligibility to five months from six. The agency also authorized a third shot for children aged 5 through 11 years who are immunocompromised. The regulatory decisions come with COVID-19 cases surging due to the Omicron variant of the virus and just as many workers and school children return from holiday vacations, raising the prospect of overwhelming health systems. Some businesses and schools closed Monday as staff called in sick.

Reuters - January 3, 2022

View the full story here: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-clears-pfizers-covid-19-booster-shot-12-15-year-olds-2022-01-03/